Back to search
Patent Ductus Arteriosus After Premature Birth
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Patent Ductus Arteriosus After Premature Birth trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Patent Ductus Arteriosus After Premature Birth trials you may qualify forPatent ductus arteriosus (PDA), the most common cardiovascular complication of prematurity, is associated with higher mortality and morbidities in extremely low…
Background: Among preterm infants, those born at a gestational age less than 26 weeks are considered the most vulnerable with a high risk of short- and long-ter…
Purpose of the research Everyone is born with an opening between the chambers of the heart, called a ductus arteriosus. In most people, it closes on its own, bu…
Multicentric, double-blind clinical trial, which will evaluate the efficacy of iv paracetamol versus standard treatment with ibuprofen in the closure of patent…
Estimate the risks and benefits of active treatment versus expectant management of a symptomatic patent ductus arteriosus (sPDA) in premature infants.